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1. Introduction 
Tissue engineering and cell therapy represent significant emerging technologies in 
medicine. Tissue engineering is‚ "the persuasion of the body to heal itself, through the 
delivery to the appropriate sites of molecular signals, cells and supporting structures" 
(Williams, 1999). Various approaches have been described which are labelled tissue 
engineering, which form a continuum from complex regeneration of scaffold-based tissues 
to more simple cell-based therapies, where these supporting structures are usually absent or 
are present in the form of gels simply to aid cell delivery or encapsulation. In tissue 
engineering the implant to be delivered may frequently be a near mature functional product 
or a cell-seeded tissue scaffold, both derived in a bioreactor (Haycock, 2011). For cell-based 
therapies, a bioreactor is not necessary but may be used to amplify the cell numbers for the 
therapy. Indeed, a key element for both approaches is that they normally require significant 
expansion of the replacement cells, which have typically been derived in low numbers from 
small biopsy samples (Brittberg et al., 1994; Chiang et al., 2005; Thissen et al., 2005). A 
consequence of this expansion is that there can be a significant loss in the quality of cells 
available for the procedure. 
In many cases, monolayer cell culture has been the method of choice for cell expansion 
(Brittberg, 1999; Brittberg et al., 1994; Henderson et al., 2007). However, while this method is 
well established and simple it has problems. One of these is that certain cells may de-
differentiate and lose their phenotype and biochemical characteristics (Arterburn et al., 1995; 
Mallein-Gerin et al., 1991). For example, in extended culture, chondrocytes lose their 
rounded morphology (Fig. 1A) and develop an extended, fibroblast like appearance (Fig. 
1B). Also, accompanying this morphological change, matrix biosynthesis switches from type 
II collagen to type I collagen (Aulthouse et al., 1989; Lefebvre et al., 1990; von der Mark et al., 
1977). It is clear that the collagen produced changes from type II collagen (Fig. 2A), which is 
the characteristic collagen of articular, hyaline cartilage (Mayne, 1989; Miller & Matukas, 
1969) to type I collagen (Fig. 2B), which is a mechanically-inferior fibrocartilage (Chiang et 
al., 2005; Wegener et al., 2009). Type I collagen is the principal collagen of many tissues, 
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including skin, bone, ligament and tendons. It is also present in poorly functioning 
fibrocartilage which can be observed in some arthritic conditions (Aulthouse et al., 1989; 
Lefebvre et al., 1990; von der Mark et al., 1977). Depending on the cell type, variations in 
media or other conditions can potentially be used to extend the control on phenotype and 
biochemical characteristics. For example, lowering of the amount of oxygen has been 
suggested for control of chondrocyte phenotype in monolayer cultures (Malda et al., 2003), 
but the positive effect may be limited, possibly to around 10 days (Malda et al., 2003, Oesser 
& Seifert, 2003), which is less time than would typically be needed for cell expansion for cell 
therapy applications (Brittberg et al., 1994). Stem cells, especially embryonic stem cells have 
particular difficulties in maintaining stemness in culture and current trends are aimed at 
developing specialised media or scaffold-based bioreactors to expand these types of cells.  
Chondrocytes have been a cell type of particular interest as they are the cell used in a major 
cell therapy application, autologous chondrocyte implantation (ACI). The development of 
ACI has proved to be a particularly useful innovation for certain types of cartilage defects 
(Brittberg et al., 1994; Brittberg, 1999), and is now an established cell-based therapy for 
regeneration of certain types of articular cartilage damage. Defects of articular cartilage in 
the knee do not have the capacity to self repair (Hippocrates, cited by Hunter, 1742-1743). A 
range of surgical techniques have been proposed for repair of damage and pain relief. These 
include debridement, abrasion, mosaicplasty and microfracture (Bedi et al., 2010). A range 
of grafting options have also recently been developed, including osteochondral autografts 
and allografts and periosteal grafting (Hunziker, 2001; Shah et al., 2007). In ACI a cartilage 
biopsy sample is taken from the patient that yields low numbers of chondrocytes, which 
then must be expanded several fold to give sufficient cells for the regeneration procedure. In 
ACI, the cell expansion takes place in monolayer culture and may take 21 days or longer 
(Brittberg et al., 1994; Chiang et al., 2005; Henderson et al., 2005). As a consequence, the 
majority, if not all, of the implanted cells are likely to have lost their chondrocyte 
characteristics. This compromises the regeneration of a true hyaline cartilage after implant 
(Brittberg, 1999; Hunziker, 2001; Temenoff & Mikos, 2000). Several other variants on this 
chondrocyte-based techniques have subsequently been proposed to give tissue regeneration 
constructs that are placed and secured in the defect (Bartlett et al., 2005; Marlovits et al., 
2005). These methods, including ACI, provide methods for pain relief and extend the time 
period before a total knee reconstruction is required.  
There are clear deficiences in using monolayer culture for cell expansion. An alternative 
culture system that has been developed is based on spinner culture for cells in suspension 
(McLimans et al., 1957), which was subsequently adapted to use beads as cell microcarriers 
(van Wezel, 1967). Microcarriers have have been shown to provide clear advantages for cell 
expansion, as the rate of cell expansion can be considerably greater, and for chondrocytes, 
the cell phenotype, including the biochemical characteristics, is substantially, if not fully 
retained (Frondosa et al., 1996; Malda et al., 2003, 2006). Compared to monolayer culture, the 
mechanical effects that are present in spinner culture may lead to positive effects on certain 
cell types (Freeman et al., 1994). A wide range of microcarriers have been developed, 
predominantly based on synthetic materials, which provide a wide range of surface 
chemistries, such as negatively and positively charged and capable of further modification 
to introduce biological functions (Jacobson & Ryan, 1982).  
The benefits of using spinner culture for chondrocyte expansion for potential application to 
ACI were initially demonstrated using non-resorbable beads (Frondoza et al., 1996; Lahiji et 
al., 2000), and spinner culture was shown to be significantly superior to monolayer culture, 
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with excellent proliferation rates achieved while the cells retained their phenotype 
(Frondosa et al., 1996). In addition, chondrocytes cultured on a variety of bead types in 
spinner culture systems have a greater ability to re-differentiate to the differentiated 
phenotype (Lee et al., 2011; Malda et al., 2003).  
 
 
Fig. 1. De-differentiation of chondrocytes in monolayer culture to fibroblast-like phenotype. 
(A)  Cells after 3 days in culture, starting to show some elongated characteristics,  (B)  Cells 
after 6 days in culture, showing a predominately elongated, fibroblast-like shape 
 
 
Fig. 2. De-differentiation of chondrocytes in monolayer culture to fibroblast-like phenotype, 
with collagen production identified by immune-histological staining. (A)  Immunostaining 
for type II collagen production by cells after 3 days in culture. (B)  Immunostaining for type 
I collagen production by cells after 6 days in culture 
Various approaches are available for making beads that would potentially be suitable for 
cell therapy, and several types, for example Cytodex™ beads (Fig. 3A), are commercially 
available for cell culture. In some cases the beads are biodegradable, for example, resorbable 
synthetic polymeric (PLGA) beads (Fig. 3B) have been described, including those with 
surface modifications to enhance cell attachment (Chen et al., 2006; Hong et al., 2008; 
Thissen et al., 2005).  
A B 
A B 
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Fig. 3. Chondrocytes in culture on synthetic beads. (A)  Culture for 6 days on Cytodex™ 
beads coated by absorption with type II collagen, showing retention of a round cell 
morphology. (B)  Culture for 12 days on PLGA beads (Thissen et al., 2005) coated by 
absorption with type II collagen, showing proliferation of cells with rounded morphology 
Natural, extracellular matrix tissues can also be used to make beads for spinner culture, and 
some, for example highly crosslinked gelatin, Cultispher™, are commercially available. 
Natural tissue-based beads have a range of advantages compared with synthetic beads, 
including the presence of natural cell binding and growth factor binding sites, a three 
dimensional environment including variation in surface topography, in vivo resorption 
using normal biochemical pathways, and when crosslinking is introduced, control of the 
resorption rate can be achieved (Glattauer et al., 2010). These beads can often be readily 
processed for cell isolation; for example, mildly crosslinked gelatin beads can be readily 
dispersed using trypsin or collagenase allowing easy separation of cells by filtration. A wide 
range of possible beads has been described, along with various approaches for manufacture. 
Beads can be made of natural tissue components (Glattauer et al., 2010), including those 
based on powdered acellular dermis (Cymetra™) (Maloney et al., 2004), porous collagen beads 
that are formed after removal of an alginate carrier (Tebb et al., 2007), or mildly, <0.5% 
(Glattauer et al., 2010) or heavily, >>1%, cross-linked gelatin (Tao et al., 2003).  
If cells are expanded for cell therapy using an in vivo biodegradable, resorbable bead, then 
there is no need to isolate the cells from the beads prior to administration (Glattauer et al., 
2010; Werkmeister et al., 2006). Inclusion of the resorbable beads as an integral part of the 
therapy procedure provides the advantage of minimizing the extent of cell handling and 
eliminating a final trypsin treatment to detach cells from the beads. Delivery of a cell/bead 
construct is also preferably performed using a gel system so that an appropriate distribution 
of the material is obtained and the cell/bead construct can be readily administered. A gel 
delivery system could be a synthetic polymer, preferably one that could be cured in situ to 
prevent migration after delivery of the cell/bead materials, while maintaining sufficient 
porosity to allow cell respiration and growth (Adhikari et al., 2010; Gunatillake et al., 2006; 
Werkmeister et al., 2010). Another good material for a delivery system is collagen. When 
cold solutions of soluble collagen are warmed to body temperature, 37 °C, the soluble 
collagen forms into fibrils and a gel then forms (Gross and Kirk, 1958). This gel is 
biocompatible, and has been the basis for soft tissue augmentation technology (Knapp et al., 
1978; Kaplan et al., 1983). Hence, with use of cell/bead constructs, where the cells do not 
A B 
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require final removal after the expansion phase and can be implanted directly as a 
cell/bead/gel delivery system, the "curing" of the collagen delivery gel will hold the 
cell/bead constructs in place. In addition, the potential presence of some extracellular 
matrix (ECM) that had accumulated during culture (Frondosa et al., 1996; Tebb et al., 2007; 
Thissen et al., 2005) could assist in retaining the cells at the desired implant location. When 
resorbable beads are used for cell expansion and then direct delivery of cells, it is possible to 
design suitable carrier beads with a range of stabilities that matches the implant requirements. 
2. Materials and methods 
2.1 Preparation of beads 
2.1.1 Gelatin beads 
Solid gelatin-based beads with cross-linking throughout the bead were produced as 
previously described (Glattauer et al., 2010). Briefly, 20% w/v porcine A-type gelatin, 270-
300 g Bloom (Sigma, St Louis, MO) in 50 mM acetic acid was heated to 50 °C and dispersed 
at 10% v/v in olive oil at 37 °C by rapid stirring. After 90 min, the emulsion was transferred 
to 4 °C and stirred for 30 min. Beads were separated from oil by 3 extractions with 0.2% 
Triton X-100 in phosphate buffered saline, and then cross-linked by addition of selected 
concentrations of glutaraldehyde (GA) ranging from 0.005% to 0.1%. Cross-linked beads 
were further extracted with 0.2% Triton X-100 in phosphate buffered saline, water and 
finally EtOH. Beads were collected by filtration and freeze dried.  
2.1.2 Gelatin/collagen beads 
For gelatin/collagen beads containing type I or II collagen, collagen was added to cooled, 37 
°C, gelatin to give a 10% w/w collagen to gelatin mixture immediately prior to emulsion 
formation, as for gelatin only beads. Soluble bovine hide type I collagen and soluble bovine 
articular cartilage type II collagens were prepared using pepsin digestion (see below). 
2.1.3 Collagen beads 
Collagen beads, based on co-formation with alginate followed by alginate removal were 
prepared as previously described (Tebb et al., 2007). 
Collagen beads can also be formed by an emulsion method, similar to that used to prepare 
gelatin beads (see above). Type I collagen in phosphate buffered saline, pH 7.3, at 8 mg/ml 
and 4 °C was dispersed at 10% v/v in olive oil at 12 °C by rapid stirring. After 15 min, the 
emulsion was heated quickly to 37 °C and stirred very gently. The collagen was allowed to 
gel for 3 h at 37 °C. The collagen gel beads were then stabilised by addition of 0.1% w/v 
glutaraldehyde and were crosslinked overnight. Beads were washed, as above for the 
gelatin beads, collected and freeze dried, followed by ethylene oxide sterilisation prior to 
use. The typical size range prior to fractionation, eg: by sieving, was 100-200 µm. 
2.1.4 Bone based beads 
Powdered bovine bone particles were obtained from Waitaki Biosciences (Christchurch, NZ) 
and were sieved to give a 70 to 150 µm fraction. For production of demineralised bone 
(DMB) particles, the bovine bone particles were suspended in either 0.6 M HCl, or 0.5 M 
EDTA at pH 7.4, and stirred for 16 h at 4°C. After settling, solutions were removed by 
decanting. Particles were then further extracted each day for 6 days using the same 
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conditions, before being washed and freeze dried (Glattauer et al., 2010). A 70 to 150 µm 
fraction was collected by sieving. The loss of Ca was confirmed as previously described 
(Glattauer et al., 2010). 
2.1.5 Endosteal particles 
Endosteal particles from bovine bone marrow were prepared from fresh sternum from 
young calves, ~4 weeks old (Nigro et al., 2010). Briefly, dissected pieces of sternum were 
crushed in liquid nitrogen and the frozen bone marrow powder was freeze-dried. To 
decellularise the dried particles, they were suspended in water and mixed vigorously for 30 
min, and then allowed to settle. The water was replaced with 4% ethanol/0.1% peracetic 
acid and mixed vigorously for 2 h, and then allowed to settle. The solution was then 
replaced and the particles mixed with phosphate buffered saline for 15 min, and then 
allowed to settle. This wash was repeated and then the settled particles were treated with a 
cocktail of DNase I (50 U/ml) and RNase A (1 U/ml) in 10 mM Tris-HCl/2.5 mM MgCl2/0.5 
mM CaCl2, pH 7.6 for 24 h at 37 °C, with gentle agitation. The particles were washed with 
phosphate buffered saline and then water, and then exchanged into 80% v/v ethanol and 
sieved to provide a fraction between 40 - 230 µm. To remove any residual calcification, 
particles were treated with 0.6 N HCl for 16 h at 4 °C, washed three times in sterile water 
and then stored in 80% (v/v) ethanol. 
2.1.6 Basement membrane particles 
Fresh bovine testis was obtained from an abattoir. After removal of the external membranes, 
the tissue comprising the seminiferous tubules was sliced into approximately 5 x 5 x 5 mm 
pieces and was macerated on a stainless steel wire mesh to break the tissue and release cells 
with continual irrigation by phosphate buffered saline, including a protease inhibitor 
cocktail. The tubules were retained on the mesh. Samples were suspended in excess 
phosphate buffered saline containing protease inhibitor cocktail, and washed and collected 
by settling 3 times. Washed samples were examined by immunohistology to examine the 
presence of basement membrane components using antibodies to laminin (Sigma) and 
collagen type IV (Biodesign, ME) following the methods previously described (Glattauer et 
al., 2007). Basement membrane samples were fragmented further using Ultra Turrax blender 
(IKA Werke, Germany). The resulting suspension was examined by microscopy to 
determine the particle size that was present. The particles were observed to have a maximal 
dimension of 500 µm. The basement membrane particles can be fractionated if required to 
give particles of the desired size by use of mesh sieves of appropriate size.  
All collagen-based particle types were sieved to collect 70 to 150 µm fractions and were 
sterilised by ethylene oxide, except the seminiferous tubule-derived particles which were 
sanitised by soaking in 80% EtOH. Bead size distributions were verified by microscopy and 
image analysis. Unmodified Cytodex™ beads (Amersham Biosciences, Sweden) were used 
as a synthetic control bead and were sterilised prior to use by autoclaving. 
2.2 Culture of chondrocytes 
2.2.1 Isolation of chondrocytes 
Ovine chondrocytes were isolated from fresh articular cartilage by digestion of 1 mm3 pieces 
with 10 % trypsin (2 ml/g) (MP Biomedicals), for 1 h at 37 °C, followed by 300 units/ml 
bacterial collagenase (354 U/ml Clostridium histolyticum, type IAS, Sigma, St Louis, MO) and 
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760 units/ml hyaluronidase (2 ml/ g) (760 U/ml bovine testicular type IV-S, Sigma, St Louis, 
MO), for 16 h at 37 °C. Cells were collected through a 70 µm filter, and washed and counted 
prior to seeding. Human articular chondrocytes were obtained from Edward Keller (Cambrex 
BioScience, Mount Waverley, Australia), (EK 23-7-02, KN8823) and maintained in complete 
chondrocyte medium (F12:DMEM, 1:1, containing 10% FCS, plus 1 mM glutamine and 10 mM 
2-mercaptoethanol);  comparable results were obtained with both the ovine and human cells. 
2.2.2 Chondrocyte seeding and culture on beads 
Cells were seeded onto the various microcarrier beads and cultured in spinner bottles, with 
an initial density of 5 x 105 cells/150 mg particles in 50ml DMEM/F12/10% FBS containing 
100 µg/ml penicillin and streptomycin, at 37 ºC in 5% CO2. Cell seeding was performed 
with initial 25 rpm intermittent stirring for 2 min every 30 min. After 3 h, the stirring speed 
was increased to 45 rpm, intermittently as above, for 1.5 h, followed by continuous stirring 
at 15 min intervals at 45, 50, 55 and finally 60 rpm. After 24 h in culture, the efficiency of cell 
attachment onto the beads was monitored.  
2.2.3 Mesenchymal stem cell seeding and culture on particles 
Mesenchymal stem cells were obtained and seeded as previously described (Nigro et al., 
2010). A settled volume (0.45 ml) of particles was exchanged into 50 ml MEM/20% FCS/5 
ng/ml FGF-2 before adding 2.5 x 105 mesenchymal stem cells in a spinner flask. The flask 
was stirred at 25 rpm for 2 min every 30 min at 37 °C with 5%CO2. After 24 h, the spinner 
flask was set to stir at 25 rpm continuously. After 7 days, a sample of the mesenchymal stem 
cells/particle construct was taken and cell viability was assessed using Calcein-AM. Images 
were captured with a fluorescence microscope (Olympus). 
2.3 Collagen materials 
2.3.1 Isolation and preparation of collagen 
Type I bovine collagen was isolated and purified from bovine dermis by pepsin digestion (1 
mg/ml) in 50 mM acetic acid at 4 °C as previously described (Ramshaw, 1986). Type I 
collagen was collected by precipitation by 0.7 M NaCl, and was the further purified by 
differential salt precipitation at neutral pH (Trelstad et al., 1976). Type II collagen from bovine 
articular cartilage was isolated in a similar manner. The purified bovine collagens were 
dialysed exhaustively against 20 mM acetic acid and then freeze dried and stored at -20 °C.  
2.3.2 Preparation of collagen gels 
To prepare collagen gels, purified collagen was dissolved at 3 mg/ml in 50 mM acetic acid. 
Once dissolved, the solution was taken to 1 M acetic acid and sealed in a dialysis bag and 
held against 1 M acetic acid for 24 h. It was then dialysed exhaustively against water 
followed by 20 mM acetic acid and then taken to about 25 mg/ml by air evaporation at 
room temperature. Finally, while still maintaining the seal of the dialysis tube, it was taken 
to 4 °C and dialysed against water and then phosphate buffered saline, prior to removal 
from the dialysis bag under sterile conditions in a biohazard cabinet. 
2.3.3 Preparation of collagen gel and cell-bead composite plugs 
Cells were taken after culture on beads in a spinner culture system. Typically, 14 x 106 cells 
on 0.5 ml beads were used. This was to mimic the concentration of cells in natural hyaline 
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cartilage. The beads/cells were incorporated by mixing with 0.4 ml of 20 mg/ml type I 
collagen gel in phosphate buffered saline containing 0.1 ml of 10x concentration cell culture 
medium. The mixture was then taken into a syringe and centrifuged briefly at low speed to 
remove any air bubbles and 200 µl aliquots dispensed into 96 well tissue culture plate, 
which was then incubated at 37 °C for 1 h to allow collagen fibril formation and collagen 
gelation to occur (Gross and Kirk, 1958). The cell-bead-collagen plugs were then transferred 
into 24 well culture plates, covered with cell culture medium, and kept in culture for up to 
21 days. Ascorbate was added daily to a final concentration 50 µg/ml. 
2.4 Evaluation of tissue samples 
2.4.1 Histological evaluation 
Samples were processed for conventional histology to examine the extent of bead and 
particle degradation as well as the extent of cellular infiltration into the collagen/bead 
(particle) plugs. Stains used were standard Haematoxylin and Eosin and Alcian Blue at pH 
2.5 and pH 5.8. 
2.4.2 Immunohistological evaluation 
Immunohistology staining used specific antibodies against collagen types I, II, VI and other 
extracellular matrix components. Prior to staining with antibodies, cultured cells on beads 
were washed in warm phosphate buffered saline, and then pre-fixed in ice cold methanol. A 
range of antibodies was used to assess the type of matrix: goat anti-collagen type II 
(Southern Biotechnology, Birmingham, AL), goat anti-collagen type I (Southern 
Biotechnology, Birmingham, AL), mouse monoclonal anti-collagen type VI (1D8-F8/Col6) 
(Werkmeister et al., 1993) and mouse monoclonal anti-keratan sulphate (5D4, Seikagaku 
Corp., Tokyo, Japan). Beads were incubated with antibodies for 1 h, washed and then 
reacted with corresponding FITC-conjugated secondary antibodies, rabbit anti-goat IgG 
(Southern Biotechnology, Birmingham, AL) or sheep anti-mouse Ig (Silenus, Melbourne, 
Australia). As controls in all studies, primary antibodies were omitted and replicate slides 
were stained with only secondary FITC-labeled antibodies.  
3. Results and discussion 
3.1 Production of collagen-based beads 
We have successfully prepared a wide range of biological, collagen-based beads from a 
variety of starting tissues. These include beads based solely on gelatin, the denatured form 
of collagen, and on gelatin mixed with non-denatured collagen (Fig. 4) which are readily 
formed by an emulsion method. Further stabilisation by crosslinking is then used, as 
otherwise the gelatin beads would not be stable at the 37 °C required for the subsequent cell 
culture. In the present case, glutaraldehyde has been used as the crosslinking agent. 
Variation in the extent of the glutaraldehyde crosslinking allows control of the rate of 
turnover of the beads (Glattauer et al., 2010). A wide range of other crosslinking agents are 
also possible (Ramshaw et al., 2000) which have also been used successfully in biomedical 
materials for clinical applications. The gelatin beads formed regular spheres with a 
reasonably smooth surface (Fig. 4A), although at high power, using SEM, some texture is 
present (Glattauer et al., 2000)  The gelatin beads containing either 10% w/w collagen type I 
or type II were again uniform spheres, but in this case both showed some surface texture 
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(Fig. 4C, Fig. 4E). When the beads were dehydrated in EtOH, the gelatin beads retained their 
spherical shape (Fig. 4B), while the collagen containing beads became irregular in shape 
(Fig. 4D, Fig. 4F). However, when these beads were re-hydrated for cell culture they 
generally returned to their previous spherical shape. 
Beads can also be made from collagen alone, without the gelatin component, by various 
approaches. For example, the emulsion approach used for gelatin (Fig. 4A) can be adapted 
for use with collagen. In this case the collagen solution at neutral pH must be kept cold 
during the emulsification stage, so as to prevent fibril formation. Once an emulsion has been 
formed, it is then warmed to 37 °C which causes the collagen to form fibrils (Gross & Kirk, 
1958) and then stable gel particles. Like the gelatin beads, these can then be further stabilised 
by crosslinking using glutaraldehyde or other reagents (Fig. 5).  
Alternatively, collagen beads can be formed by the use of a carrier during the bead forming 
stage, which is subsequently removed. For example (Fig. 6) alginate has been used as an 
easy and effective carrier system. In this case a mixture of alginate with collagen that 
contains a high proportion, ~30-40%, of collagen can be formed, and beads are produced by 
dropwise (aerosol) addition to 1.5% CaCl2 (Tebb et al., 2007). The CaCl2 leads to the 
precipitation of the alginate to form stable beads, and the collagen can be stabilised by fibril 
formation and crosslinking as required. The alginate phase can be removed by treatment 
with Na citrate, giving a collagen only bead (Tebb et al., 2007). An advantage of this method 
is that the collagen beads are quite porous, and cell infiltration readily occurs (Tebb et al., 
2007). Other materials could be used as carriers, including gelatin and other proteins. The 
collagen triple-helix structure is generally highly stable to proteolytic action, and pepsin 
treatment is often used during its preparation (Miller & Rhodes, 1982). So a protein carrier, 
such as gelatin, can be removed by proteolysis, leaving porous collagen beads.  
Collagen beads can also be formed directly from tissue. For example, Cymetra™ is prepared 
from acellular human dermis by fragmentation (Maloney et al., 2004) and is used clinically 
for tissue augmentation and equivalent procedures. The particles can also be used readily as 
a cell growth substrate.  
An alternate source of collagen beads or particles is from natural collagen containing tissues. 
The principle protein component of bone is type I collagen. Hence bone particles themselves 
may present surface collagen to cells to enhance binding (Fig. 7A). Bone particles can be 
refined using demineralisation, for example with EDTA or HCl, to produce beads enriched of 
collagen (Glattauer et al., 2010) (Fig. 6B). There are also low levels of growth factors and 
other biological macromolecules that can add to the effectiveness of the collagen particles in 
promoting cell adhesion and proliferation. The type and quantity of these molecules may 
vary depending on the method used to demineralise the tissue and may vary between 
batches (Wildermann et al., 2007). However, when chondrocytes were grown on particles 
prepared by both these methods no significant difference was seen in the proliferation rate 
for the cells (Glattauer et al., 2010). The bone and demineralised bone particles differ 
significantly from the previous gelatin and collagen beads in that they are irregular in shape, 
have an irregular surface topography, and do not need additional crosslinking as they are 
already fully stabilised by the naturally occuring collagen crosslinks. Any soluble collagen 
would be removed during the demineralisation process. The demineralised bone particles are 
preferred for spinner culture as they are more bouyant and hence easier to use. Whereas the 
area of smooth spherical beads in an aliquot, such as synthetic beads or gelatin beads, can be 
readily calculated from the size distribution of the beads, this is more difficult for irregular 
shaped beads, and beads with variations in surface topology.  
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Fig. 4. Production of gelatin and gelatin/collagen beads. Beads in phosphate buffered saline 
(A, C, E) and after dehydration in EtOH (B, D, F). After rehydration, these beads returned to 
their original size and shape. (A, B)  Gelatin beads, average hydrated bead size prior to 
fractionation, 106 ± 20µm. (C, D)  Gelatin/10% w/w type I collagen beads, average hydrated 
bead size prior to fractionation, 169 ± 53µm. (E, F)  Gelatin/10% w/w type II collagen beads, 
average hydrated bead size prior to fractionation, 159 ± 53µm 
A B 
C D 
E F 
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Fig. 5. Collagen beads prepared by an emulsion method 
 
 
Fig. 6. Production of type II collagen beads using an alginate carrier (Tebb et al., 2007), with 
type II collagen at 6.6 mg/ ml and alginate at 0.3% during initial bead formation. Bead size  
~ 0.7 mm 
 
 
Fig. 7. Examples of  (A)  bone particles, and  (B)  demineralised bone particles 
A B 
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The gelatin, collagen and bone particles are all based principally on type I collagen. Other 
collagens are abundant in different tissues. For example, type II collagen is the collagen 
found in normal hyaline cartilage (Mayne, 1989; Miller and Rhodes, 1982) and which could 
be used to make type II collagen particles by tissue fragmentation and further processing, if 
required, to remove other components such as proteoglycan. Similarly, type III collagen is a 
major component of blood vessels, along with type I collagen and elastin (Hanson & 
Bentley, 1983; McCloskey and Cleary, 1974). Hence, particles rich in type III collagen could 
be prepared by processing arterial tissue. Type IV collagen is the major collagen component 
of basement membranes. Basement membranes are unique, highly organised supportive 
sheet-like structures in the extracellular matrix that are formed at the interface between 
parenchymal cells and their surrounding tissues (Yurchenco et al., 2004). There are different 
types of basement membranes in the body. Some act as a tissue boundary where certain cells 
can attach; some can act as filters with selective permeability, and some support very 
selective cellular differentiation of a number of different cell types, including stem cells. The 
basement membrane comprises a range of specific macromolecular components. As well as 
type IV collagen, which may be important for mechanical properties (Yurchenco et al., 2004), 
the other components are laminin, nidogen and heparan sulphate proteoglycans, such as 
perlecan, which are believed to interact in a highly ordered manner with type IV collagen 
(Yurchenco et al., 2004).  
Thus, we have shown that by using natural tissues from different origins, it is also possible 
to make other tissue derived particles. By having different protein and other 
macromolecules present, these have the potential to provide different interactions with 
various cell types. An example is the production of particles from the endosteum of bone 
(Fig. 8) (Nigro et al., 2010). This tissue is proximal to the location of haematopoetic stem cells 
(Haylock et al., 2007) and so may be useful in the proliferation of this cell type. The particle 
composition is distinct; examination of the composition using immunohistology showed 
that they contain perlecan and some laminin, suggesting similarity to a basement 
membrane, but collagen type IV was not detected (Nigro et al., 2010). 
 
 
Fig. 8. Decalcified endosteal particles 
Basement membrane particles can also be formed from a range of other tissues, including 
placenta, muscle and kidney (Werkmeister et al., 2006). In the present example, particles 
have been prepared from seminiferous tubules. The tubules are readily isolated from testis 
tissue (Fig. 9A), and immunohistological analysis has shown that the major components of 
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collagen IV (data not shown) and laminin (Fig. 9B) have been retained during the 
processing. Further fragmentation can be used to prepare particles (Fig. 9C). The 
composition of this basement membrane is distinct (Glattauer et al., 2007) showing the 
presence of various laminin types based on the positive staining for the ǂ3, ǂ4, ǂ5 and ǂ6 
chain of collagen type IV and the positive staining of various laminin chains, including the 
ǂ2 and ǃ2 chains. This composition is distinct from that of the commercial basement 
membrane material, Matrigel™, which is based on (ǂ1)2ǂ2 type IV collagen and ǂ1ǃ1Ǆ1 
laminin (laminin 111)(Kleinman & Martin, 2005). Matrigel™ has been used extensively for 
addressing cell attachment so a different composition basement membrane may provide a 
useful alternative option for cell culture. 
 
 
Fig. 9. Seminiferous tubule-based particles. (A)  Fragments of isolated seminiferous tubules. 
(B)  Immunostaining of isolated seminiferous tubules, showing the retention of laminin 
during the processing. (C)  Seminiferous tubules particles after further fragmentation of 
isolated tubules 
3.2 Cell compatibility of beads 
To be useful, any bead must clearly not be cytotoxic and must allow ready attachment and 
growth of cells. All the beads and particles described above (Figs. 3-9) meet these criteria. 
There was no evidence of any cytotoxicity due to residual glutaraldehyde that had been 
used to crosslink some of the beads. 
 
 
Fig. 10. Gelatin-based beads with chondrocytes after 3 days in spinner culture, showing 
good attachment and retention of the round chondrogenic phenotype. (A)  Gelatin beads,  
(B)  Gelatin/Type I collagen beads,  (C)  Gelatin/Type II collagen beads 
A C B 
A B C 
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As an example, chondrocytes readily attach to gelatin and gelatin/collagen beads and are 
viable and starting to proliferate after 3 days in culture (Fig. 10). Similarly, cells readily 
attach and start to proliferate on bone (Fig. 11A) and demineralised bone particles (Fig. 11B). 
Attachment and growth of chondrocytes was good on the seminiferous tubule particles, 
even after only 2 days in culture (Fig. 12). 
 
 
Fig. 11. Chondrocytes growing on bone particles. (A)  Sheep chondrocytes on bone particles 
after 3 days in spinner culture,  (B)  Human chondrocytes on demineralised bone particles 
after 4 days in spinner culture 
 
 
Fig. 12. Human chondrocytes growing on bovine seminiferous tubule particles for 2 days 
3.3 Cell growth rate on beads 
Previous studies (Frondoza et al., 1996) had suggested that cell proliferation of chondrocytes 
on synthetic microcarrier beads was superior to that found in monolayer culture. The 
present work using biologically based beads supports this finding (Fig. 13). Thus, over a 21 
day period, with cell collection and re-seeding after 7 and 14 days, the spinner culture using 
both gelatin and demineralised bone particles was significantly better than that found using 
monolayer cultures. In all cases, the bead experiments were established so that the surface 
area of the carriers was equivalent to that used in the monolayer cultures. The cell yield for 
A B 
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the gelatin beads was almost one order of magnitude greater than with monolayer cell 
culture (Fig. 13). The performance of demineralised bone particles was even better, being 
better than 2 orders of magnitude greater than for monolayer culture. As similar culture 
conditions were used for both the gelatin and demineralised bone particles, this reflects the 
differences in surface compositions and the surface topography of the two bead types as 
well as the potential for the demineralised bone particles to contain some active growth 
factors that may boost cell proliferation (Wildemann et al., 2007). Comparisons in an 
additional experiment including other bead systems (Table 1) showed that proliferation 
rates were consistently better for biological, collagen-based beads when compared to 
monolayer culture and a synthetic bead. 
 
 
Fig. 13. Proliferation of human chondrocytes in monolayer culture and in spinner culture 
using different microcarrier systems. The initial loading was 0.25 x 106 cells on beads that 
gave equivalent surface areas of ~125 cm2  (equivalent to 5 T25 monolayer flasks. ● 
monolayer culture, ♦ spinner culture using gelatin beads, ▲ spinner culture using 
demineralised bone particles 
 
Culture system Bead/particle type Proliferation rate after 21 days 
Monolayer n/a 5.5 
Spinner Culture Cytodex 6.5 
Spinner Culture Gelatin 38.4 
Spinner Culture Bone 37.2 
Spinner Culture Demineralised bone 47.2 
Table 1. Comparison of the proliferation rate for human chondrocytes obtained using 
different culture systems. The proliferation rate was determined relative to the initial 
number of cells that were seeded 
3.4 Extracellular matrix production in culture 
In the present study we have focussed principally on chondrocytes. In these cases, with a 
variety of different beads in spinner culture, newly formed extracellular matrix was found 
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to accumulate around the beads and cells, causing clumps of tissue-like material to form in 
the cultures. This was clearly evident by 7 days, for example, with gelatin and 
gelatin/collagen beads (Fig. 14), where a matrix of cells and collagen can be seen holding 
most beads in clumps.  
 
 
Fig. 14. Growth of chondrocytes on various beads after 7 days in spinner culture, showing 
the clumping of beads due to the formation of new extracellular matrix. (A)  Gelatin beads,  
(B)  Gelatin/Type I collagen beads,  (C)  Gelatin/Type II collagen beads 
Histology, using Haematoxylin and Eosin staining (Fig. 15) shows the presence of this new 
connective tissue with cells throughout. Not all cells have migrated from the beads into this 
new matrix and some are still stained on the bead surfaces. A similar result is seen for 
chondrocytes grown in spinner culture on bone particles (Fig. 15C).  
 
 
Fig. 15. Haematoxylin and Eosin staining of the growth of chondrocytes on various beads 
after 7 days in spinner culture, showing the new extracellular matrix that is formed  (A)  
Gelatin beads,  (B)  Gelatin/Type I collagen beads,  (C)  Bone particles 
With the porous collagen beads, the initial phase of cell proliferation was mainly infiltration 
of the collagen bead and less accumulation of cells and extracellular matrix external to the 
particles and hence less clumping was observed than with the gelatin beads (Fig. 16). On the 
other hand, a small amount of clumping of particles was also observed when human 
mesenchymal stem cells were grown on decalcified endosteal particles for 7 days. Cell 
attachment was good and proliferation had commenced, but was not as advanced as seen 
for chondrocytes on other bead systems (Fig. 17). 
A B C 
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Fig. 16. Growth of chondrocytes for 7 days on porous collagen beads prepared through 
alginate removal (Tebb et al., 2007), showing infiltration of the beads by cells 
 
 
Fig. 17. Growth of human MSCs for 7 days on decalcified endosteal particles. (A)  Cells 
attached to particles,  (B)  staining with Calcein-AM, which stains cell cytoplasm, and  (C)  
Merging of the previous 2 images 
 
 
Fig. 18. Haematoxylin and Eosin staining of the growth of chondrocytes on various beads 
after 21 days in spinner culture, showing the formation of new extracellular matrix. (A)  
Gelatin beads,  (B)  Gelatin/Type I collagen beads,  (C)  Gelatin/Type II collagen beads 
After longer periods of culture, 14-21 days, continued extracellular matrix production was 
seen when ascorbate was included, and cell proliferation also occured. After 21 days, 
A C B 
A B C 
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Haematoxylin and Eosin staining of materials containing gelatin and gelatin/collagen beads 
showed extensive matrix between particles (Fig. 18), which were now more separated than 
in the 7 day clusters (Figs. 14 & 15). In addition, the particles containing collagens were now 
showing erosion and degradation (Fig. 18B, Fig. 18C), while the gelatin alone particles were 
still substantially intact (Fig. 18A). Alcian Blue staining of these samples confirmed that the 
gelatin alone beads were more stable than those containing collagen (Fig. 19) and showed 
that the extracellular matrix contained proteoglycans/glycosaminoglycans which are key 
products of chondrocytes and are indicators of proper cell function and cartilage formation. 
The staining was strongest around the periphery of the particles where cells were still 
attached. The chondrocyte cell phenotype was also examined by immunohistology (Fig. 20). 
This showed that after 14 days in spinner culture the chondrocytes were still producing type 
II collagen, the correct collagen for articular (hyaline) cartilage formation, and the amount of 
type I collagen being produced was very low (Fig. 20).  
 
 
Fig. 19. Alcian Blue staining of the growth of chondrocytes on various beads after 21 days in 
spinner culture, showing the formation of proteoglycans within the new extracellular matrix. 
(A)  Gelatin beads,  (B)  Gelatin/Type I collagen beads,  (C)  Gelatin/Type II collagen beads 
 
 
Fig. 20. Immunohistological staining of chondrocytes grown on gelatin beads in spinner 
culture for 14 days, showing continued production of type II collagen and little, if any type I 
collagen production. (A)  Immunostaining for type II collagen,  (B)  Immunostaining for 
type I collagen 
A B C 
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3.5 Bead culture in a collagen carrier gel 
It was noted earlier, in the Introduction, that if cells are expanded for cell therapy on 
biodegradable, resorbable beads, then there is no need to isolate the cells from the beads 
prior to administration (Glattauer et al., 2010; Werkmeister et al., 2006), and that this has the 
advantage of minimizing the extent of cell handling that is required. In such a system, 
delivery of the cells/bead in a gel or gel forming material has further advantages. The 
presence of the gel stabilises the cell implant, and aids in the delivery of the cell/bead 
constructs. 
Collagen type I gel is an ideal FDA approved protein that can be used as the delivery 
vehicle. When mixed with the cell/bead constructs the mixture can still be readily delivered 
through a 22-gauge needle, while the particles with bound cells remain uniformly dispersed 
and do not settle out rapidly (see Fig. 21A, where the particles have been stained to 
highlight the distribution in the gel). On warming to 37 °C for 1 h, the collagen formed a 
fibrous, solid gel that was able to be picked up, if required (Fig. 21B). This would not be 
necessary for in situ application of the mixture by injection into tissue. Indeed, we have 
injected a solution of cell/bead constructs in collagen gels and found that the mixture gelled 
in situ and gel contraction was markedly reduced by the presence of the beads (data not 
shown).  
The cell/bead constructs embedded in a collagen gel can be maintained in culture for 
greater than 3 weeks. During the initial stages of culture, within 3 days, if synthetic, 
unmodified Cytodex™ beads are used, the cells show a greater affinity for the collagen of 
the gel than the bead and migrate from the beads into the surrounding gel. Cell migration is 
much slower from gelatin and other biologically–seeded beads where there seems a possible 
better affinity for the bead. 
 
 
Fig. 21. Delivery of cell/bead constructs using a collagen gel. (A)  Stable dispersion of 
gelatin beads, after staining, in a 1% collagen type I gel. (B)  Collagen gel with beads, after 
heating to 37 °C forms a mechanically stable gel 
After 3 weeks in static culture, the cell/gelatin beads/collagen gel construct had a tissue-like 
appearance (Fig. 22), and the loose structure of the original gel construct had formed a firmer, 
more compact structure, which showed very minimal contraction. When cells are seeded into 
collagen gels alone, the gel contracts significantly, by ~50% or more, within the first 7 days of 
culture (Ramshaw et al., 1991) and again forms a more compact tissue-like format.  
A B 
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Fig. 22. A collagen type I gel with cells/gelatin beads after 3 weeks in static culture, showing 
the tissue–like material that is formed 
The presence of the beads appears to retard any contraction of the collagen gel, while at the 
same time the synthesis of extracellular matrix augments the structure. Chondrocytes in 
culture can produce matrix metalloproteinases (Lefebvre et al., 1990) which could degrade 
the construct. The presence of the beads, where the cells have formed an established matrix 
prior to incorporation in the collagen gel may minimise the production of these proteinases. 
However, after 2 to 3 weeks of culture some erosion of gelatin beads was seen (Fig. 23A, Fig. 
23B). The extent of this erosion was greater than when the collagen delivery gel was absent 
(Fig. 18A). 
 
 
Fig. 23. Histological examination of cell-bead constructs in a collagen gel after 2-3 weeks in 
culture. (A)  Haematoxylin and eosin staining after 2 weeks of culture,  (B)  Alcian Blue 
staining after 3 weeks in culture, and  (C)  Immunostaining of Type II collagen after 2 weeks 
in culture 
The presence of new extracelluar matrix can be seen by histochemical and specific 
immunohistological staining. Heamatoxylin and Eosin staining after 2 weeks of culture (Fig. 
23A) shows extensive cell infiltration of the collagen gel, and new collagen synthesis around 
the beads and within the gel. Alcian Blue staining after 3 weeks of culture (Fig. 23B) shows 
significant deposition of proteoglycan/glycosaminoglycan within the gel surrounding the 
beads, as well as very strong staining around the beads themselves. This staining was not 
present in the original collagen gel and is therefore indicative of new matrix production. 
A B C 
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This is also the case for type II collagen production. Immunohistology after 2 weeks of 
culture (Fig. 23C) shows that there is type II collagen accumulation, possibly at low levels, 
throughout the matrix, while there is strong staining around the beads. 
4. Conclusions 
The data presented in this Chapter show that a wide variety of collagen-based beads and 
particles can be made which are useful for spinner culture. The beads can be made with a 
range of tissue-like conformations, ranging from denatured collagen (gelatin) through to 
beads that are based around basement membrane and collagen type IV structures. The 
beads, including those that have been further crosslinked using glutaraldehyde, were not 
cytotoxic and readily supported cell growth. The cell growth in spinner culture was 
excellent and within 7 days there was normally accumulation of new extracellular matrix. 
For cell therapy applications, the proliferation rates of chondrocytes were excellent, several 
fold better than monolayer cultures and synthetic beads. While most biological tissue based 
particles or biologically fabricated beads were excellent cell carriers, demineralised bone 
particles and gelatin beads were particularly good, the former possibly augmented by 
residual growth factors. In a therapeutic application the demineralised bone-based beads 
could have a fairly long resorption rate. If a shorter resorption rate was preferred, then 
gelatin beads are ideal, and the rate of resorption can be controlled by varying the extent of 
glutaraldehyde stabilisation (Glattauer et al., 2010). After longer times in culture, exceeding 
21 days, the chondrocytes maintained their phenotype and were still producing 
macromolecules characteristic of native articular cartilage, such as proteoglycans and type II 
collagen. For therapeutic applications a superior approach is to deliver the cell/bead 
constructs in a delivery gel; in the present study a gel of type I collagen has been used. In 
this case the choice and design of the beads can be selected to match the requirements with 
respect to cell type and bead resorption rate. These gel constructs were shown to be stable, 
retaining their size and becoming more robust with new matrix accumulation. Again the 
chondrocytes maintained their phenotype over 21 days, as shown by proteoglycan and 
collagen type II production.  
Together, these data show the utility of expanding cells on biological, collagen-based beads 
in spinner culture for tissue engineering and cell therapy applications. Further, these data 
also show that an ideal approach is to use resorbable beads for cell expansion and then 
direct delivery of cells still attached to the beads, where it is possible to design carrier beads 
with a range of stabilities that matches the implant requirements. An ideal way of achieving 
this implant is to combine the cells/beads together with a delivery gel. This proposed 
approach has been used in an animal trial for articular cartliage repair, where it was 
compared to a standard ACI approach (Chiang et al., 2005). The results strongly confirmed 
the validity of the proposed method, with an independent multifactor scoring system 
showing that the cell/bead/gel approach was significanly better than a standard ACI 
procedure and a non-cell control in a mini-pig model (Chiang et al., 2005). The approach can 
be further improved by examining delivery systems that allow the delivery and stabilisation 
of the cell/bead construct by arthroscopy, removing the need for open knee surgery. Equally, 
although the present techniques use cartilage biopsies obtained from non-load bearing 
cartilage, recent developments in cell biology, for example the ready acquisition of 
mesenchymal stem cells which can be differentiated into chondrocytes, opens up further 
opportunities that may minimise invasive surgery for the patient. 
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